157 related articles for article (PubMed ID: 2513643)
1. Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole.
Solcia E; Rindi G; Havu N; Elm G
Scand J Gastroenterol Suppl; 1989; 166():129-37; discussion 138-9. PubMed ID: 2513643
[TBL] [Abstract][Full Text] [Related]
2. Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth.
Creutzfeldt W; Lamberts R
Digestion; 1992; 51 Suppl 1():76-81. PubMed ID: 1397748
[TBL] [Abstract][Full Text] [Related]
3. Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment.
Solcia E; Fiocca R; Havu N; Dalväg A; Carlsson R
Digestion; 1992; 51 Suppl 1():82-92. PubMed ID: 1397749
[TBL] [Abstract][Full Text] [Related]
4. Quantitative studies of gastric endocrine cells in patients receiving long-term treatment with omeprazole.
Creutzfeldt W; Lamberts R; Stöckmann F; Brunner G
Scand J Gastroenterol Suppl; 1989; 166():122-8; discussion 138-9. PubMed ID: 2513642
[TBL] [Abstract][Full Text] [Related]
5. Marked increase in gastric acid secretory capacity after omeprazole treatment.
Waldum HL; Arnestad JS; Brenna E; Eide I; Syversen U; Sandvik AK
Gut; 1996 Nov; 39(5):649-53. PubMed ID: 9026477
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural morphometry of gastric endocrine cells before and after omeprazole. A study in the oxyntic mucosa of duodenal ulcer patients.
D'Adda T; Pilato FP; Lazzaroni M; Robutti F; Bianchi-Porro G; Bordi C
Gastroenterology; 1991 Jun; 100(6):1563-70. PubMed ID: 2019362
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.
Brunner GH; Lamberts R; Creutzfeldt W
Digestion; 1990; 47 Suppl 1():64-8; discussion 76. PubMed ID: 2093018
[TBL] [Abstract][Full Text] [Related]
8. Gastric ECL-cell hyperplasia and carcinoids in rodents following chronic administration of H2-antagonists SK&F 93479 and oxmetidine and omeprazole.
Betton GR; Dormer CS; Wells T; Pert P; Price CA; Buckley P
Toxicol Pathol; 1988; 16(2):288-98. PubMed ID: 2903544
[TBL] [Abstract][Full Text] [Related]
9. Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists.
Klinkenberg-Knol EC; Jansen JB; Lamers CB; Nelis F; Snel P; Meuwissen SG
Scand J Gastroenterol Suppl; 1989; 166():88-93; discussion 94. PubMed ID: 2574911
[TBL] [Abstract][Full Text] [Related]
10. Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
Lundell L
Digestion; 1990; 47 Suppl 1():72-5. PubMed ID: 2093020
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.
Klinkenberg-Knol EC; Festen HP; Jansen JB; Lamers CB; Nelis F; Snel P; Lückers A; Dekkers CP; Havu N; Meuwissen SG
Ann Intern Med; 1994 Aug; 121(3):161-7. PubMed ID: 8017742
[TBL] [Abstract][Full Text] [Related]
12. Ghrelin expression in hyperplastic and neoplastic proliferations of the enterochromaffin-like (ECL) cells.
Srivastava A; Kamath A; Barry SA; Dayal Y
Endocr Pathol; 2004; 15(1):47-54. PubMed ID: 15067176
[TBL] [Abstract][Full Text] [Related]
13. Gastric polyps and nodules in children receiving long-term omeprazole therapy.
Pashankar DS; Israel DM
J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):658-62. PubMed ID: 12454582
[TBL] [Abstract][Full Text] [Related]
14. Combined use of omeprazole and a novel antioxidative cytoprotectant for the treatment of peptic ulcer. Facilitation of ulcer healing in experimental animals.
Kim JM; Choi SM; Kim DH; Oh TY; Ahn BO; Kwon JW; Kim WB
Arzneimittelforschung; 2005; 55(7):387-93. PubMed ID: 16080278
[TBL] [Abstract][Full Text] [Related]
15. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
[TBL] [Abstract][Full Text] [Related]
16. Controlled clinical trials of omeprazole in the long-term management of reflux disease.
Hetzel DJ
Digestion; 1992; 51 Suppl 1():35-42. PubMed ID: 1397745
[TBL] [Abstract][Full Text] [Related]
17. [Morphological variations of the human gastric mucosa after omeprazole treatment: a scanning electron microscopic study].
Magaudda L; Mondello MR; Di Mauro DD; Pallio S; Bottari M
Minerva Gastroenterol Dietol; 1996 Jun; 42(2):61-9. PubMed ID: 8962907
[TBL] [Abstract][Full Text] [Related]
18. Histology of gastric biopsies from peptic ulcer patients before and after short-term treatment with omeprazole or H2-receptor antagonists.
Helander HF; Simonsson M; Sundler F; Rutgersson K; Helander KG; Eriksson S
Virchows Arch A Pathol Anat Histopathol; 1990; 417(4):305-9. PubMed ID: 1978433
[TBL] [Abstract][Full Text] [Related]
19. An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
Brunner G; Arnold R; Hennig U; Fuchs W
Aliment Pharmacol Ther; 1993; 7 Suppl 1():51-5, discussion 61-6. PubMed ID: 8490080
[TBL] [Abstract][Full Text] [Related]
20. Gastric endocrine cells in omeprazole-treated and untreated patients with the Zollinger-Ellison syndrome.
Bardram L; Thomsen P; Stadil F
Digestion; 1986; 35 Suppl 1():116-22. PubMed ID: 3792668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
